INOVIQ

Welcome to the Brand page for “INOVIQ”, which is offered here for The mark consists of the wording inoviq to the right of a design of three concentric rings of dots.;pharmaceutical, biotechnology and medical preparations and substances (for medical use or purposes); diagnostic preparations and reagents for medical purposes; antibodies; antibody fragments; antibody conjugates; preparations for the treatment, reconstruction and repair of antibodies; immunological antibodies for medical use; monoclonal antibodies for diagnostic use (medical); monoclonal antibodies for medical use; monoclonal antibodies for therapeutic purposes; products containing antibodies for use in medicine; proteins for medical use in binding antibodies; proteins for medical use in detecting antibodies; reagents for use in the development of monoclonal antibodies (for medical purposes); molecular targets and associated information for drug and vaccine development, all in the nature of biological reagents; tagged antibodies for medical use; vaccines; vaccines against cancer viral or bacterial infection; vaccines for human use; vaccine adjuvants; diagnostic preparations, reagents, substances, products and testing materials for medical purposes; reagents for use in diagnostic tests (for medical purposes); reagents for medical research applications (for diagnosis); recombinant human protein production cell line; proteins for medical use in recombinant dna technology; biological reagents for use in molecular biology;color is not claimed as a feature of the mark.;biotechnology apparatus (for medical use or purposes); apparatus for sale in kit form for medical diagnostic purposes;scientific research, clinical research, development, advisory and consultancy services in relation to antibody production; drug discovery; vaccine screening, in the nature of (or for) research and development of vaccines; advisory services relating to diagnostic products; diagnostic testing services; medical research services; scientific research for medical purposes; pharmaceutical research services; diagnostic and research services and screening in the nature of research services in the field of diagnostic preparations; preparation of reports relating to medical, scientific and technical research; provision of information relating to medical, scientific and technical research; research and development of products; laboratory research; laboratory services (scientific research or analysis); analysis of tissues for medical research; antibody generation services being research and development services; molecular target discovery and development being services in this class;.

Its status is currently believed to be active. Its class is unavailable. “INOVIQ” is believed to be currently owned by “INOVIQ Limited”.

Owner:
INOVIQ LIMITED
Owner Details
Description:
The mark consists of the wording INOVIQ to the right of a design of three concentric rings of dots.;Pharmaceutical, biotechnology and medical preparations and substances (for medical use or purposes); diagnostic preparations and reagents for medical purposes; antibodies; antibody fragments; antibody conjugates; preparations for the treatment, reconstruction and repair of antibodies; immunological antibodies for medical use; monoclonal antibodies for diagnostic use (medical); monoclonal antibodies for medical use; monoclonal antibodies for therapeutic purposes; products containing antibodies for use in medicine; proteins for medical use in binding antibodies; proteins for medical use in detecting antibodies; reagents for use in the development of monoclonal antibodies (for medical purposes); molecular targets and associated information for drug and vaccine development, all in the nature of biological reagents; tagged antibodies for medical use; vaccines; vaccines against cancer viral or bacterial infection; vaccines for human use; vaccine adjuvants; diagnostic preparations, reagents, substances, products and testing materials for medical purposes; reagents for use in diagnostic tests (for medical purposes); reagents for medical research applications (for diagnosis); recombinant human protein production cell line; proteins for medical use in recombinant DNA technology; biological reagents for use in molecular biology;Color is not claimed as a feature of the mark.;Biotechnology apparatus (for medical use or purposes); apparatus for sale in kit form for medical diagnostic purposes;Scientific research, clinical research, development, advisory and consultancy services in relation to antibody production; drug discovery; vaccine screening, in the nature of (or for) research and development of vaccines; advisory services relating to diagnostic products; diagnostic testing services; medical research services; scientific research for medical purposes; pharmaceutical research services; diagnostic and research services and screening in the nature of research services in the field of diagnostic preparations; preparation of reports relating to medical, scientific and technical research; provision of information relating to medical, scientific and technical research; research and development of products; laboratory research; laboratory services (scientific research or analysis); analysis of tissues for medical research; antibody generation services being research and development services; molecular target discovery and development being services in this class;
Categories: